Project Grant R01AI197111
Award Date 9/3/25
Completion Date 8/31/29
Dollars Obligated $161K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Atlanta, GA 30322, USA
Similar Awards
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855), provides $147,486.00 to Emory University to develop novel methods for assessing the pandemic potential of influenza A viruses. The project aims to accomplish this through two approaches: 1) using data from animal transmission studies to estimate key epidemiological parameters like the basic reproduction number and...
- This $146,922 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research at Emory University to study factors modulating the efficiency of influenza A virus (IAV) infection. The researchers will conduct intranasal and aerosol inoculations in guinea pigs to model direct and airborne transmission of IAV, using barcoded viral libraries to assess the intensity of exposure. They will also test...
- This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $640,735.00 to Emory University to conduct research on understanding the mechanisms of CD8+ tissue-resident memory T cells (TRM) that mediate protection against respiratory virus transmission. The research aims to investigate the characteristics, durability, and molecular mechanisms of respiratory tract TRM...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $3,182,827 Project Grant to Duke University to develop a 3D bioprinted alveolar sac model and dual host-microbe spatial transcriptomics technology. The goal is to enhance understanding of how the lung microbiome regulates the host response to influenza virus infection. This Allergy and Infectious Diseases Research (CFDA 93.855) program grant will fund the creation of innovative in vitro technologies to study interactions...
- This $1,173,748.00 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will fund research on the role of asymptomatic tuberculosis (TB) in disease transmission. The research aims to improve understanding of when individuals become infectious and where transmission is occurring, particularly in community settings outside of household contacts. Key areas of focus include characterizing...
- This $137,064 federal Project Grant was awarded on July 25, 2025 by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research (CFDA 93.855) program. The grant will fund a 2-year study at the University of Florida to develop new system science models for dynamically measuring and validating people's accessibility to healthcare services. The research aims to address limitations in current static, population-based approaches by...
- This federal Project Grant award of $422,814.00 was provided by the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research (CFDA 93.855) program. The project aims to develop and apply adversarial machine learning methods to predict the risk of animal viruses spilling over into humans, accounting for virus evolution. Key objectives include (i) predicting human-infection risk for viral sequence variants, (ii) characterizing and...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $822,015 Project Grant titled "NOVEL STATISTICAL METHODS FOR CONFOUNDED AND INCOMPLETE NETWORK DATA" to the University of Pennsylvania. This grant, provided under the NIAID's Allergy and Infectious Diseases Research program (CFDA 93.855), will fund the development of new statistical methodologies to address challenges posed by missing data, confounding, and complex social network structures in studies of public...
- The National Institute of Allergy and Infectious Diseases (NIAID), through its Allergy and Infectious Diseases Research federal grant program (CFDA 93.855), awarded a $4,874,388 Cooperative Agreement to Duke University on June 13, 2025. The award will fund the "Center for Multiscale Immune Systems Modeling - The Center of Excellence (COE)", a research initiative that brings together experts to develop innovative solutions for multi-scale modeling in infectious and immune-mediated...
- This federal Project Grant award of $705,557 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to better understand the coordination of innate and cellular mucosal immunity in SARS-CoV-2 clearance. The primary objectives are to determine the contribution of monocytes in promoting T cell responses and viral control within the respiratory tract, and to define the effector mechanisms of...